Harrisburg, NC -- (SBWIRE) -- 10/22/2020 -- Biosimilars Global Market Report 2020 provides insightful data about business strategies, qualitative and quantitative analysis of Global Market. The report also calls for market – driven results deriving feasibility studies for client needs. MarketInsightsReports ensures qualified and verifiable aspects of market data operating in the real- time scenario. The analytical studies are conducted ensuring client needs with a thorough understanding of market capacities in the real- time scenario.
The global biosimilars market was worth $7.79 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 31.70% and reach $23.63 billion by 2023.
Inquire here to Avail Discount on this Report:
https://www.marketinsightsreports.com/reports/05072013897/biosimilars-market-global-report-2020-30-including-1-by-product-recombinant-non-glycosylated-proteins-recombinant-glycosylated-proteins-2-by-types-human-growth-hormone-erythropoietin-monoclonal-antibodies-insulin-interferon-granulocyte-colony-stimulating-factor-others-3-by-application-oncology-chronic-and-autoimmune-diseases-growth-hormone-deficiency-infectious-diseases-others-covering-pfizer-amgen-biocon-celltrion-dr-reddy-s-laboratories/inquiry?Mode=PD11
Top Leading Companies Mentioned are Pfizer, Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Boehringer Ingelheim, Elli Lilly and Company, Mylan N.V., Sanofi, and STADA Arzneimittel.
The rising prevalence of chronic diseases such as arthritis, asthma, and cancer is expected to be a major driver of the biosimilars market. Long working hours, limited physical activity, unhealthy eating and drinking habits contribute to the prevalence of chronic diseases and biosimilars are increasingly used to treat these chronic diseases. Biosimilars activate the immune system response against cancer cells thus helping the immune system to eliminate the cancer cells from the body. According to a United Nations article, by 2030 the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic disease is expected to reach about 60%. Therefore, the rise in the prevalence of chronic diseases is projected to propel the demand for biosimilars, thus driving the biosimilars market.
The lack of awareness about biosimilars among primary care physicians (PCPs) and specialists limits the growth of the biosimilars market. Biosimilars are manufactured from cell lines and offer the same effectiveness as biologics. However, lack of familiarity with biosimilars reduces the likelihood of prescribing the drugs to patients which affects the demand for new biosimilars in the market. For instance, in 2018, according to the PwC's Health Research Institute, out of 442 clinicians surveyed 55% of clinicians were unfamiliar with biosimilars and 35% were reluctant to prescribe them due to concerns included safety of the follow-on biologic. Thus, the lack of awareness about biosimilars among primary care physicians (PCPs) and specialists restricts the growth of the biosimilars market.
This report provides a detailed analysis of the Biosimilars market with description of market sizing and growth, segmentation of market by products & services and major markets, top market players etc. The report recapitulates the factors that will be responsible for the growth in the market in the forecasted period.
Following are major Table of Content of Biosimilars Industry:
Biosimilars Market Sales Overview.
Biosimilars Market Sales Competition by Manufacturers.
Biosimilars Market Sales Analysis by Region.
Biosimilars Market Sales Analysis by Type.
Biosimilars Market Analysis by Application.
Biosimilars Market -Manufacturers Analysis.
This independent 200 pages report guarantees you will remain better informed than your competition. With over figures examining the Biosimilars market, the report gives you a visual, one-stop breakdown of the leading products, submarket and market leader's market revenue forecasts as well as analysis to 2030.
Geographically, this report is segmented into several key Regions, with Sales, revenue, Market Share (%) and Growth Rate (%) of Biosimilars in these regions, from 2015 to 2030(forecast), covering Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa.
Browse Full Report at:
https://www.marketinsightsreports.com/reports/05072013897/biosimilars-market-global-report-2020-30-including-1-by-product-recombinant-non-glycosylated-proteins-recombinant-glycosylated-proteins-2-by-types-human-growth-hormone-erythropoietin-monoclonal-antibodies-insulin-interferon-granulocyte-colony-stimulating-factor-others-3-by-application-oncology-chronic-and-autoimmune-diseases-growth-hormone-deficiency-infectious-diseases-others-covering-pfizer-amgen-biocon-celltrion-dr-reddy-s-laboratories?Mode=PD11
Furthermore, the report provides a detailed analysis of the global Biosimilars market with analysis of market size by value and volume. Along with this, an analysis of penetration rate and the average revenue generated per user (ARPU) in the market has also been done. The report also includes a detailed analysis of the global Biosimilars market by countries, comprising of its market by value, volume, and ARPU and penetration rate.
Key Points of this Report:
-Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
-Create regional and country strategies on the basis of local data and analysis.
-Identify growth segments for investment.
-Outperform competitors using forecast data and the drivers and trends shaping the market.
-Understand customers based on the latest market research findings.
-Benchmark performance against key competitors.
-Utilize the relationships between key data sets for superior strategizing.
-Suitable for supporting your internal and external presentations with reliable high quality data and analysis
-Report will be updated with the latest data and delivered to you within 3-5 working days of order.
The research includes historic data from 2015 to 2020 and forecasts until 2030 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs. The report will make detailed analysis mainly on above questions and in-depth research on the development environment, market size, development trend, operation situation and future development trend of Biosimilars on the basis of stating current situation of the industry in 2020 so as to make comprehensive organization and judgment on the competition situation and development trend of Biosimilars Market and assist manufacturers and investment organization to better grasp the development course of Biosimilars Market.
How we have factored the effect of Covid-19 in our report:
All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.
About MarketInsightsReports
MarketInsightsReports provides syndicated Market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. MarketInsightsReports has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Contact US
Irfan Tamboli (Head of Sales)
sales@marketinsightsreports.com | irfan@marketinsightsreports.com